Net income sharply declined with the contraction of overseas sales, Botai Biology opens up the microfluidic testing field | Earnings conference

①The rapid decline in overseas income dragged down the performance of Botuo Life Sciences, with overall revenue significantly decreasing compared to before the epidemic, and net income attributable to shareholders has decreased year-on-year for multiple years; ② Considering changes in the external environment, Botuo Life Sciences has terminated two major core investment projects, added the Microfluidic Fluorescence Detection Platform project, and ventured into the microfluidic technology field.

cls.cnNov 11 13:04

Recently, the first stock was suspended for investigation due to abnormal stock price fluctuations! A star market speculative stock has hit the limit for 7 consecutive days at 20 centimeters.

①Haoyoubo was suspended for investigation after seven consecutive trading days of limit up from October 31 to November 8 due to serious abnormal fluctuations in stock trading, becoming the first stock to be suspended for this reason recently. ②The company mainly engages in the research, development, production, and sale of in vitro diagnostic reagents, with revenue of 0.307 billion and net income of 26.56 million in January-September 2024.

cls.cnNov 8 19:58

Star Evening News | zhe jiang headman machinery co.,ltd. was listed on the SDN list by the Office of Foreign Assets Control (OFAC) of the usa. Haobo: pe is significantly higher than the industry average.

1. Harmontronics Automation Technology: Planning to sell 81% equity of its subsidiary Borui Autos; 2. Jiangsu Eazytec Co., Ltd.: Planning to repurchase shares for 30 million yuan to -60 million yuan; 3. Traffic Control Technology Consortium won the bid for the signal system project of Phase I of Chongqing Rail Transit Line 24 with a bid amount of 0.28 billion yuan.

cls.cnNov 6 20:58

Shandong pharmaceutical glass: October sales performance better than Q3 average level, current overall costs remain relatively stable | Direct hit earnings conference

①Regarding the situation in Q4, Zhang Jun, the General Manager of shandong pharmaceutical glass, stated that the declining business in Q3 has shown some improvement. According to the current situation, it is expected that Q4 will be better than Q3; ②In terms of costs, while the price of the main raw material caustic soda has decreased, energy prices have risen, resulting in overall costs remaining stable.

cls.cnNov 5 13:31

STAR Evening News | Hao Europe Borg Holdings' shareholder control changes, stocks to resume trading tomorrow, Suzhou Veichi Electric plans to establish Asia Vets robot&automation project

1. As an electric autos company, BYD Company Limited's quarterly revenue exceeded Tesla for the first time; 2. Six departments: promoting the installation of photovoltaic systems on existing building roofs; 3. Three departments: supporting the IPO financing of relevant enterprises that meet the conditions of new materials big datacenter.

cls.cnOct 30 21:17

Shenzhen Mindray Bio-Medical Electronics Q3 net income fell by 9.31% due to factors such as delayed hospital purchases and sluggish non-rigid medical demand. | Financial report

Affected by factors such as delayed hospital procurement, tight hospital construction funds, and low non-rigid medical demand, in the third quarter, Shenzhen Mindray Bio-Medical Electronics' net income decreased by 9.31% year-on-year, while total revenue increased by 1.43% year-on-year. In the second interim profit distribution for 2024, Shenzhen Mindray Bio-Medical Electronics will distribute 16.50 yuan for every 10 shares.

wallstreetcnOct 29 20:55